These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 8171003)

  • 41. Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant.
    Balboni PG; Bozzini R; Zucchini S; Marconi PC; Grossi MP; Caputo A; Manservigi R; Barbanti-Brodano G
    J Med Virol; 1993 Dec; 41(4):289-95. PubMed ID: 8106862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficiency of reinitiation of translation on human immunodeficiency virus type 1 mRNAs is determined by the length of the upstream open reading frame and by intercistronic distance.
    Luukkonen BG; Tan W; Schwartz S
    J Virol; 1995 Jul; 69(7):4086-94. PubMed ID: 7769666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional classification of simian immunodeficiency virus isolated from a chimpanzee by transactivators.
    Sakuragi J; Sakai H; Sakuragi S; Shibata R; Wain-Hobson S; Hayami M; Adachi A
    Virology; 1992 Jul; 189(1):354-8. PubMed ID: 1604820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency.
    Pomerantz RJ; Seshamma T; Trono D
    J Virol; 1992 Mar; 66(3):1809-13. PubMed ID: 1738210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A tripartite HIV-1 tat-env-rev fusion protein.
    Salfeld J; Göttlinger HG; Sia RA; Park RE; Sodroski JG; Haseltine WA
    EMBO J; 1990 Mar; 9(3):965-70. PubMed ID: 2178928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tat and Rev: positive regulators of HIV gene expression.
    Rosen CA; Pavlakis GN
    AIDS; 1990 Jun; 4(6):499-509. PubMed ID: 2201316
    [No Abstract]   [Full Text] [Related]  

  • 48. Limitation of Tat-associated transcriptional processivity in HIV-infected PBMC.
    Adams M; Wong C; Wang D; Romeo J
    Virology; 1999 May; 257(2):397-405. PubMed ID: 10329550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene.
    Ranga U; Woffendin C; Yang ZY; Xu L; Verma S; Littman DR; Nabel GJ
    J Virol; 1997 Sep; 71(9):7020-9. PubMed ID: 9261432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.
    Poon B; Chang MA; Chen IS
    J Virol; 2007 Oct; 81(19):10515-23. PubMed ID: 17652391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
    Dave RS; Pomerantz RJ
    J Virol; 2004 Dec; 78(24):13687-96. PubMed ID: 15564478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Residual expression of reporter genes in constructs mimicking HIV genome organization.
    Chenciner N; Pedroza Martins L; Hanania N; Stratford Perricaudet L; Perricaudet M; Wain-Hobson S
    Res Virol; 1995; 146(3):171-8. PubMed ID: 7481089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.
    Buonaguro L; Barillari G; Chang HK; Bohan CA; Kao V; Morgan R; Gallo RC; Ensoli B
    J Virol; 1992 Dec; 66(12):7159-67. PubMed ID: 1279199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.
    Woffendin C; Yang ZY; Udaykumar ; Xu L; Yang NS; Sheehy MJ; Nabel GJ
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11581-5. PubMed ID: 7972106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains.
    Tähtinen M; Ranki A; Valle SL; Ovod V; Krohn K
    Biomed Pharmacother; 1997; 51(10):480-7. PubMed ID: 9863510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitors of HIV-1 gene expression and transcription.
    Baba M
    Curr Top Med Chem; 2004; 4(9):871-82. PubMed ID: 15134546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
    Staffa A; Cochrane A
    Mol Cell Biol; 1995 Aug; 15(8):4597-605. PubMed ID: 7623851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
    Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
    Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.